"Acute Bilateral Neuroretinitis and Panuveitis in A Patient with Coronavirus Disease 2019 : A Case Report"- Few Comments
During the Coronavirus Disease 2019 (COVID-19) pandemic, we have witnessed increase in number of reports of a known uveitic entity being associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Causal relation is yet to be proven for many reports. Perhaps, occurrence of a previously known region-specific endemic disease or closely resembling manifestations of a known disease in a non-endemic region during the COVID-19 pandemic might suggest a causal relationship. Epidemic retinitis (ER) or post fever retinitis is such condition with geographic variation. Occurrence of ER or ER-like manifestations in a non-endemic country during the pandemic should instigate further studies to consider SARS-CoV-2 as a causative organism.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 31(2023), 3 vom: 08. Apr., Seite 671-672 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kawali, Ankush [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID |
---|
Anmerkungen: |
Date Completed 31.03.2023 Date Revised 31.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2022.2039212 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337893829 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337893829 | ||
003 | DE-627 | ||
005 | 20231225235441.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2022.2039212 |2 doi | |
028 | 5 | 2 | |a pubmed24n1126.xml |
035 | |a (DE-627)NLM337893829 | ||
035 | |a (NLM)35258394 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kawali, Ankush |e verfasserin |4 aut | |
245 | 1 | 0 | |a "Acute Bilateral Neuroretinitis and Panuveitis in A Patient with Coronavirus Disease 2019 |b A Case Report"- Few Comments |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.03.2023 | ||
500 | |a Date Revised 31.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a During the Coronavirus Disease 2019 (COVID-19) pandemic, we have witnessed increase in number of reports of a known uveitic entity being associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Causal relation is yet to be proven for many reports. Perhaps, occurrence of a previously known region-specific endemic disease or closely resembling manifestations of a known disease in a non-endemic region during the COVID-19 pandemic might suggest a causal relationship. Epidemic retinitis (ER) or post fever retinitis is such condition with geographic variation. Occurrence of ER or ER-like manifestations in a non-endemic country during the pandemic should instigate further studies to consider SARS-CoV-2 as a causative organism | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID | |
650 | 4 | |a Epidemic retinitis | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a coronavirus disease 2019 | |
650 | 4 | |a neuroretinitis | |
650 | 4 | |a post fever retinitis | |
650 | 4 | |a severe acute respiratory syndrome coronavirus-2 | |
700 | 1 | |a Sanjay, Srinivasan |e verfasserin |4 aut | |
700 | 1 | |a Mahendradas, Padmamalini |e verfasserin |4 aut | |
700 | 1 | |a Shetty, Rohit |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 31(2023), 3 vom: 08. Apr., Seite 671-672 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2023 |g number:3 |g day:08 |g month:04 |g pages:671-672 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2022.2039212 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2023 |e 3 |b 08 |c 04 |h 671-672 |